Capital Markets

Mind Medicine in its US$30 million public offering

Mind Medicine
Key Contact
Trevor R. Scott

Partner, Corporate, Vancouver

Team
Minji Park

Associate, Corporate, Vancouver

Natalie Holtby

Associate, Corporate, Vancouver

James Chang

Associate, Tax, Toronto

Timothy Hughes

Partner, Tax, Toronto

 

On September 30, 2022, Mind Medicine (MindMed) Inc. issued 7,058,823 common shares, together with accompanying warrants to purchase 7,058,823 common shares in an underwritten public offering for gross proceeds of approximately US$30 million.

MindMed is a clinical stage biopharmaceutical company developing novel products to treat brain health disorders.

Osler, Hoskin & Harcourt LLP acted as Canadian counsel to MindMed with a team consisting of Trevor Scott, Minji Park, Natalie Holtby (Corporate), Timothy Hughes and James Chang (Tax).

Value
US$30 million
Date Closed
September 30, 2022
Lead Office
Vancouver
Key Contact
Trevor R. Scott

Partner, Corporate, Vancouver

Team
Minji Park

Associate, Corporate, Vancouver

Natalie Holtby

Associate, Corporate, Vancouver

James Chang

Associate, Tax, Toronto

Timothy Hughes

Partner, Tax, Toronto